These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2931181)

  • 1. Depression of afferent arc of the in vivo cytotoxic T-cell immunity by bacterial lipopolysaccharides.
    Mizoguchi K; Nakashima I; Hasegawa Y; Isobe K; Kato N; Shimokata K; Kawashima K; Nagase F; Ando K; Yoshida T
    Cell Immunol; 1985 Oct; 95(2):330-9. PubMed ID: 2931181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
    Winchurch RA; Hilberg C; Birmingham W; Munster AM
    J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
    Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
    Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran-triggered T cells heighten T- and B-cell reactions to mitogens.
    Alevy YG; Battisto JR
    Immunology; 1976 Mar; 30(3):379-90. PubMed ID: 1082852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
    Leshem B; Kedar E
    J Exp Med; 1990 Apr; 171(4):1057-71. PubMed ID: 2139097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
    Dziarski R
    J Immunol; 1989 Jul; 143(1):356-65. PubMed ID: 2471741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
    Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
    J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrageenan-induced decline of natural killer activity. II. Inhibition of cytolysis by adherent non-T La-negative suppressor cells activated in vivo.
    Hochman PS; Cudkowicz G; Evans PD
    Cell Immunol; 1981 Jun; 61(1):200-1. PubMed ID: 6455201
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenically activated helper T cells are required as stimulator cells for optimal activation of cytotoxic T lymphocytes under conditions of limiting helper factors.
    Moyers C; Droege W
    Cell Immunol; 1983 Jan; 75(1):1-12. PubMed ID: 6218891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging of natural and acquired immunity of mice. II. Decreased T cell responses to syngeneic tumor cells and parental-strain spleen cells.
    Fitzgerald PA; Bennett M
    Cancer Invest; 1983; 1(2):139-49. PubMed ID: 6230139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of antigen-presenting cells and suppressor cells in the ultraviolet radiation-induced inhibition of secondary cytotoxic T cell sensitization.
    Jensen PJ
    J Immunol; 1983 May; 130(5):2071-4. PubMed ID: 6220078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of the transplantation immunity of mice for rejecting ascitic allogeneic tumors.
    Ando K; Hasegawa T; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Kawashima K; Kato N; Ohashi K
    Dev Comp Immunol; 1985; 9(4):701-8. PubMed ID: 3878806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells.
    Ogasawara M; Iwabuchi K; Good RA; Onoe K
    J Immunol; 1988 Nov; 141(10):3306-12. PubMed ID: 2972771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.